Results 241 to 250 of about 181,112 (317)

Metabolites of the antipsychotic agent clozapine inhibit the replication of human immunodeficiency virus type 1

open access: hybrid, 1997
Lorraine Jones‐Brando   +4 more
openalex   +1 more source

Multiple Concomitant Precipitating Factors of Hepatic Encephalopathy Are Associated With a Poor Prognosis in Patients With Cirrhosis Admitted to Intensive Care Unit

open access: yesUnited European Gastroenterology Journal, EarlyView.
ABSTRACT Introduction Management of hepatic encephalopathy relies on the identification and control of precipitating factors (PF). The prognostic value of a PF is unknown, which we aimed to explore. Patients and Methods Single‐center retrospective study of cirrhotic patients included in a prospective cohort admitted to an intensive care unit (ICU ...
Marika Rudler   +7 more
wiley   +1 more source

Editorial: Drug repurposing for cancer treatment: current and future directions. [PDF]

open access: yesFront Oncol
Lampros M   +4 more
europepmc   +1 more source

Concomitant Use of Etrasimod With Opioids or Antidepressants in Patients With Ulcerative Colitis—A Safety Analysis

open access: yesUnited European Gastroenterology Journal, EarlyView.
ABSTRACT Background Etrasimod is an oral, once‐daily (q.d.), selective sphingosine 1‐phosphate (S1P)1,4,5 receptor modulator for the treatment of moderately to severely active ulcerative colitis (UC). Unlike the S1P receptor modulator ozanimod, etrasimod does not have a molecular structure to inhibit monoamine oxidase (MAO).
Anita Afzali   +12 more
wiley   +1 more source

Clozapine as a Model for Antipsychotic Development

open access: yesNeurotherapeutics, 2017
F. Nucifora   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy